wellrank.ai
Obesity Medicine Association logo

Obesity Medicine Association

First cited by AI Jun 12, 2026
obesitymedicine.org

Surfaced organically in AI answers about zepbound. Not yet profiled.

Obesity Medicine Association is losing the AEO war.

Not cited in a single tracked AI answer since Jun 13, 2026, down from a peak of 8% visibility in ozempic on Jun 13, 2026. This page and its history stay public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Ozempic, daily share of AI answers mentioning Obesity Medicine Association, through Jun 14, 2026.

0.0%

Last cited Jun 13, 2026 · peak 8% on Jun 13

By engine

Where Obesity Medicine Association is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 2 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Obesity Medicine Association

PerplexityJun 13, 2026, 11:12 UTC
What are the best alternatives if I cannot get Ozempic, and who prescribes them online?

Based on current medical guidelines and available online services (as of 2026), here are the best alternatives to Ozempic (semaglutide) and information on which providers prescribe them online. Best Alternatives to Ozempic If you cannot access Ozempic, the most effective alternatives are other GLP-1 receptor agonists or dual GIP/GLP-1 agonists. These work similarly by regulating appetite and blood sugar. FDA-Approved Injectable Alternatives (Weight Loss) Wegovy (Semaglutide): The most direct alternative. It contains the exact same active ingredient as Ozempic but is FDA-approved specifically for chronic weight management. Dosage:* Starts at 0.25 mg/week, increasing to 2.4 mg/week. Zepbound (Tirzepatide): A newer, highly effective dual GIP/GLP-1 agonist. Clinical data often shows it leads to greater weight loss than semaglutide alone. Dosage:* Starts at 2.5 mg/week, increasing to 15 mg/week. Saxenda (Liraglutide): An older GLP-1 agonist approved for weight management (since 2014). It is effective but generally requires daily injections rather than weekly. Note:* An authorized generic of liraglutide (active ingredient in Saxenda/Victoza) is now available, potentially lowering costs. FDA-Approved Oral Alternative Rybelsus (Semaglutide): The first oral GLP-1 medication. It contains the same active ingredient as Ozempic and Wegovy. Use:* Primarily FDA-approved for Type 2 diabetes but often prescribed for weight loss. Benefit:* Ideal for patients who dislike needles. Other Prescription Options (Non-GLP-1) If GLP-1s are not accessible or suitable, doctors may prescribe: Contrave (Naltrexone-Bupropion): Combines two drugs to affect brain appetite/reward centers. Orlistat (Xenical/Alli): Blocks fat absorption. (Xenical is prescription; Alli is OTC). Phentermine (Adipex/Suprenza): A short-term stimulant for appetite suppression. Metformin: Often used for Type 2 diabetes; sometimes prescribed off-label for weight management (less effective than GLP-1s). Who Prescribes Them Online? Several reputable telehealth platforms specialize in weight loss and can evaluate you via video or questionnaire to prescribe these medications. Important Note: Legitimate providers will not prescribe these medications without a review of your medical history, and they often require a recent blood test (which can be done at a local lab like Quest or LabCorp) to ensure safety. Top Telehealth Providers for Weight Loss: Ro (formerly Ross Health): What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Dedicated "Go" program for weight loss; offers medication management and coaching. Hims & Hers Health: What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Integrates medication with lifestyle coaching; very popular for online prescriptions. Klarity (Klarity Health): What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Focuses on connecting patients with local doctors for telehealth visits. Wellness Wanderer (or similar specialized clinics): Many specialized obesity medicine clinics (like Obesity Medicine Association members) offer remote consultations. NovoCare Pharmacy & LillyDirect: Note: These are manufacturer programs, not prescribers. If you have a prescription from any* doctor (online or in-person), you can use these services to get Wegovy or Zepbound shipped directly, often at a lower cash price (e.g., $650 for Wegovy, $399–$650 for Zepbound). How to Get Prescribed Online: Sign Up: Choose a provider (e.g., Ro, Hims, Hers). Medical Review: Complete a health questionnaire and undergo a telehealth video consultation with a licensed provider (MD, DO, or NP). Lab Work: The provider may order a blood test (AST/ALT, kidney function, etc.) to be done at a local lab. Prescription: If approved, the medication is shipped to your home or sent to a local pharmacy for pickup. Monitoring: You will need ongoing monthly or quarterly check-ins to monitor progress and adjust dosages. Cost Considerations & Compounding Savings Coupons: Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) offer savings programs for cash-paying patients without insurance coverage for obesity drugs. Compounded Medications: Some telehealth providers offer compounded versions of semaglutide or tirzepatide as a cheaper alternative. However, the FDA has issued warnings about compounded GLP-1s regarding safety and purity. Always verify the provider's accreditation. Authorized Generics: If you switch to Saxenda, ask your doctor about the authorized generic liraglutide, which is significantly cheaper than the branded version. Summary Recommendation If you want the closest alternative with the same efficacy, Wegovy is the top choice. If you want the highest potential for weight loss, Zepbound is the best option. If you refuse injections, Rybelsus is your go-to. For online prescribing, Ro, Hims & Hers, and Klarity are the most established and reliable platforms for these specific medications in 2026. Always consult with a healthcare professional to ensure these medications are safe for your specific health profile.

Mentioned in position 4 of 10

Read full answer with sources →
ChatGPTJun 12, 2026, 12:00 UTC
How do I get Zepbound prescribed online?

Short answer: you can get Zepbound (tirzepatide) prescribed online through a telehealth weight‑management or primary‑care service — if you meet clinical criteria and a licensed provider evaluates you. Below are practical steps, safety points, and a few telehealth options to consider. Steps to get Zepbound prescribed online Check basic eligibility Zepbound is approved for adults with BMI ≥30, or BMI ≥27 with at least one weight‑related condition (e.g., high blood pressure, type 2 diabetes). A clinician will confirm eligibility and review your medical history. Choose a reputable telehealth or obesity clinic Book a consultation; the provider will review history, meds, and may order labs (A1c, basic metabolic panel, pregnancy test if applicable) before prescribing. Clinical evaluation The provider screens for contraindications (personal or family history of medullary thyroid carcinoma or MEN2, pregnancy/breastfeeding, pancreatitis history, etc.) and discusses risks/benefits and monitoring. Prescription, insurance/prior authorization, and delivery If prescribed, your plan may require prior authorization. The medication usually ships from a specialty pharmacy; the provider or clinic typically helps with prior auth and financial assistance options. Follow‑up and monitoring Expect scheduled follow‑ups for side effects, dose titration, and ongoing monitoring (weight, labs, glucose if diabetic). Safety and practical notes Common side effects: nausea, vomiting, diarrhea, constipation; hypoglycemia risk if you’re also on insulin or sulfonylureas. Serious but uncommon risks include pancreatitis and possible thyroid C‑cell effects. Don’t start if you are pregnant or planning pregnancy; effective contraception is recommended while on therapy. Always get the drug through a licensed provider and pharmacy — avoid buying from unverified online sellers. Telehealth services and clinics (examples) Hims & Hers — offers online weight‑management programs and prescriber visits; user‑friendly platform and nationwide availability in many states. Ro (Ro “Weight” program) — established telehealth company with structured weight‑loss programs and provider follow‑up; helps with prior auth and delivery logistics. PlushCare — board‑certified physicians and ongoing chronic care; they offer weight‑loss visits and medication management. Local/ specialty obesity care: find an obesity medicine specialist via the Obesity Medicine Association or the ABOM Diplomate Finder — good option if you prefer specialist care or have complex medical history. Cost/help Expect variable cost: insurance coverage differs and many insurers require prior authorization. Eli Lilly (the manufacturer) and clinics often have patient‑savings programs or coupons for commercially insured patients — ask the prescribing clinic for assistance. If you want, I can: Check which of those telehealth services currently prescribes tirzepatide in your state (I’ll need your state), or Draft a message you can send to a telehealth clinic to request an appointment for Zepbound evaluation.

Mentioned in position 4 of 5

Read full answer with sources →

Public AI visibility history

Daily rank of Obesity Medicine Association on our buyer intent questions, per category. A dash means the engines did not cite Obesity Medicine Association at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13Jun 14
Ozempic#46
Zepbound#72

TL;DR

The Obesity Medicine Association (OMA) is a professional medical society dedicated to advancing the practice of obesity medicine through education, advocacy, and clinical resources for healthcare providers. It does not sell consumer products or telehealth services directly, but it publishes clinical guidance and continuing medical education that are widely cited in conversations about weight-loss treatments. In WellRank's latest index it ranks fifteenth in AI-generated answers about Ozempic, carrying eight percent visibility, with all two of its AI mentions in our corpus registering as neutral in tone.

Company Overview

The Obesity Medicine Association is a nonprofit professional organization based in the United States that supports physicians, nurse practitioners, and other clinicians who treat patients with obesity. Its business model centers on membership dues, credentialing programs such as the Obesity Medicine Certification, and continuing medical education rather than direct-to-consumer telehealth or pharmaceuticals. The organization publishes clinical practice statements and hosts an annual conference that shapes how providers approach obesity care.

Product Features

  • Obesity Medicine Certification (ABOM board credential pathway)
  • Continuing medical education courses and clinical guidelines
  • Obesity Algorithm, a widely referenced visual treatment framework for clinicians
  • Membership community and peer network for obesity medicine specialists
  • Advocacy and policy resources on obesity-related legislation
  • Patient-facing educational content and provider-finder tools on obesitymedicine.org

Target Market

OMA primarily serves physicians, advanced practice providers, dietitians, and other licensed clinicians who treat adults and adolescents living with obesity across the United States. Its clinical resources are also used internationally by providers seeking evidence-based obesity medicine frameworks.

Buyer Personas

  • A primary care physician who wants to integrate GLP-1 prescribing into their practice and needs accredited CME and clinical frameworks to do so confidently.
  • A nurse practitioner or PA working in a weight-management clinic who is pursuing the Obesity Medicine Certification to advance their credentials.
  • A health system administrator or payer looking for evidence-based clinical guidelines to support obesity treatment coverage policies.
  • A telehealth platform medical director seeking reputable clinical standards to underpin their obesity care protocols.

Funding & Performance

OMA is a nonprofit professional membership association; detailed financials, revenue figures, and membership counts are not publicly disclosed.

Recent Developments

OMA has expanded its clinical guidance in response to the rapid growth of GLP-1 receptor agonists such as semaglutide and tirzepatide, publishing updated position statements and educational materials on their use. The association has also increased its public-facing content, with blog posts like its weight-loss medications overview surfacing organically in AI-generated answers about drugs like Zepbound and Ozempic. Advocacy around obesity as a chronic disease, rather than a lifestyle issue, remains a central organizational focus.

Competitive Landscape

As a professional society, OMA does not compete directly with telehealth prescribers or pharmaceutical brands, but it is consistently co-mentioned in AI answers alongside companies such as Ro, PlushCare, and LillyDirect, as well as manufacturers Eli Lilly and Novo Nordisk. Comparisons of Ozempic alternatives covered by sources like GoodRx, Health.com, and Stanford Medicine place OMA-cited guidance in the same informational ecosystem as consumer telehealth players. This positioning makes OMA a credibility anchor that commercial brands and AI engines draw on rather than a market competitor in the conventional sense.

Mentioned alongside

Brands AI engines recommend in the same breath. Your real competitive set.

User Sentiment

Within WellRank's current corpus, both AI mentions of OMA are neutral in tone, with no positive or cautious signals detected, reflecting its role as a cited authority rather than a reviewed consumer brand. Public and professional sentiment toward OMA is generally favorable among clinicians who regard its Obesity Algorithm and certification pathway as credible resources. Consumer-facing review platforms do not typically assess professional medical societies, so sentiment data is largely limited to how clinicians and health journalists reference the organization.

Pricing

OMA membership dues and certification fees vary by provider type and are published on its website; exact figures change periodically and are not reproduced here. CME course pricing is not publicly standardized. Patient-facing educational resources on the site are available at no charge.

Sources cited around Obesity Medicine Association

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Obesity Medicine Association weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Obesity Medicine Association? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.